When you see, “Wow, Fable is number one”, you might think it’s a good writer, but that’s not what the benchmark says.
898 karma · joined July 20, 2017
When you see, “Wow, Fable is number one”, you might think it’s a good writer, but that’s not what the benchmark says.
I have no reason whatsoever to use this, but it's a cool project!
Obviously, 75% of Americans do not develop dementia. Do more who are overweight develop dementia than those who are not? Well...it's hard to say when 3/4ths of the population is overweight.
The watermark: counting instances of 'load-bearing seam', 'the hard truth', 'and that's the whole point'.
Hedonic adaptation prevents us from asking "is this worth the downsides, or should we go back to how it was?"
I don't think I understand why they aren't leveraging the increased speed to do batching to serve more customers at a "normal" tok/s.
Is the limitation, even on cerberus, still that the cache can only serve so many concurrent sessions over time? Is there no scaling advantage? I genuinely do not understand how any of this works.
Until, of course, it isn’t - but at that point, the budget is reallocated, there’s no funding, there’s simply nothing we can do except continue to pay this AI contract.
Vote with your wallet works when you’re talking about local businesses. It doesn’t work when the only factor that determines where the money goes is the executives signing the contracts.
Giving agents pointers to the right patterns, libraries and services helps avoid expensive grep goose chases, but if you're already curating the input you can do the same thing with small repositories.
Tools, especially open source ones (linters, static analysis, scanning, LSPs, IDEs, etc) are not built for monorepos, and with AI Agents working in the monorepo results in an enormous increase in input tokens as the agents are constantly trying to grep this giant source tree.
I'm sure it's possible that we're doing the monorepo thing wrong, but I'm genuinely curious what the upside is that you're experiencing? Or are these drawbacks unique to our implementation?
It’s good to read others’ perspectives and expand your own. It’s even good when you disagree with the author. But you need to read multiple perspectives and adopt a habit of learning.
Cluttered old homes with lots of things all over the place make it a bit less jarring when there's a stack of work left out on a table.
Don’t count out Zuckerberg, he’s very good at being a villain.
No one benefits from PFAS being unregulated in food, other than stockholders, C-suites and the politicians who accept money from lobbyists that represent them.
Is there a limit in food, which is what this petition was about?
Based on what, exactly? Disagreeing with a publication does not make them unreliable. The Guardian's journalism is consistently award-winning and rates highly on credibility. The Guardian's opinion section is openly centre-left, though I suppose Americans would consider this to be some sort of comically ultra-left-wing communist point-of-view given the state of politics in the country.
Simple PFAS regulations have been put in place in Europe[0] and the FDA has access to the same studies and information as the EU bodies. The science has been performed. The lawsuit was to push for regulation because the FDA has been dragging their feet for years[1] and refusing to act.
[0] https://environment.ec.europa.eu/topics/chemicals/pfas-pollu...
[1] https://www.eenews.net/articles/inside-fdas-forever-chemical...
Edit: Also, note that this account was created today and has made 3 comments, 2 of which are taking potshots at The Guardian. This sort of astroturfing has no place on HN.
I don't think I understand the token/cost implications of this feature